SAGE Historical PE Ratio image   This SAGE PE ratio history page last updated 11/10/2022
SAGE Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/8/2022
33.91-2.31-9.24NA
Q2 2022
8/2/2022
35.25-2.13-8.52NA
Q1 2022
5/3/2022
32.79-2.07-8.28NA
Q4 2021
2/24/2022
34.71-2.12-8.48NA
Q3 2021
11/2/2021
43.57-2.21-8.84NA
Q2 2021
8/3/2021
41.76-1.83-7.32NA
Q1 2021
5/4/2021
71.14-1.64-6.56NA
Q4 2020
2/24/2021
85.0418.1972.761.2
Q3 2020
11/5/2020
78.11-2.03-8.12NA
Q2 2020
8/10/2020
53.31-2.08-8.32NA
Q1 2020
5/7/2020
40.76-2.44-9.76NA
Q4 2019
2/27/2020
52.01-3.25-13.00NA
Q3 2019
11/12/2019
141.55-3.48-13.92NA
Q2 2019
8/6/2019
162.34-3.28-13.12NA
Q1 2019
5/2/2019
165.52-3.37-13.48NA
Q4 2018
2/19/2019
152.95-3.38-13.52NA
Q3 2018
11/6/2018
128.26-2.63-10.52NA
Q2 2018
8/7/2018
151.20-0.36-1.44NA
Q1 2018
5/3/2018
148.13-1.68-6.72NA
Q4 2017
2/22/2018
155.40-1.75-7.00NA
Q3 2017
11/2/2017
62.56-1.97-7.88NA
Q2 2017
8/3/2017
78.40-1.88-7.52NA
Q1 2017
5/9/2017
66.03-1.52-6.08NA
Q4 2016
2/23/2017
62.33-1.50-6.00NA
Q3 2016
11/3/2016
38.71-1.15-4.60NA
Q2 2016
8/9/2016
36.86-1.08-4.32NA
Q1 2016
5/5/2016
34.79-0.97-3.88NA
Q4 2015
2/24/2016
30.75-0.99-3.96NA
Q3 2015
11/5/2015
53.03-0.84-3.36NA
Q2 2015
8/12/2015
62.47-0.90-3.60NA
Q1 2015
5/14/2015
58.29-0.66-2.64NA
Q4 2014
2/27/2015
43.45-0.57-2.28NA
Q3 2014
11/11/2014
33.98-0.50-2.00NA
Q2 2014
8/14/2014
28.81-4.57-18.28NA
SAGE PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/8/2022
33.91-2.31-8.63NA
Q2 2022
8/2/2022
35.25-2.13-8.53NA
Q1 2022
5/3/2022
32.79-2.07-8.23NA
Q4 2021
2/24/2022
34.71-2.12-7.80NA
Q3 2021
11/2/2021
43.57-2.2112.513.5
Q2 2021
8/3/2021
41.76-1.8312.693.3
Q1 2021
5/4/2021
71.14-1.6412.445.7
Q4 2020
2/24/2021
85.0418.1911.647.3
Q3 2020
11/5/2020
78.11-2.03-9.80NA
Q2 2020
8/10/2020
53.31-2.08-11.25NA
Q1 2020
5/7/2020
40.76-2.44-12.45NA
Q4 2019
2/27/2020
52.01-3.25-13.38NA
Q3 2019
11/12/2019
141.55-3.48-13.51NA
Q2 2019
8/6/2019
162.34-3.28-12.66NA
Q1 2019
5/2/2019
165.52-3.37-9.74NA
Q4 2018
2/19/2019
152.95-3.38-8.05NA
Q3 2018
11/6/2018
128.26-2.63-6.42NA
Q2 2018
8/7/2018
151.20-0.36-5.76NA
Q1 2018
5/3/2018
148.13-1.68-7.28NA
Q4 2017
2/22/2018
155.40-1.75-7.12NA
Q3 2017
11/2/2017
62.56-1.97-6.87NA
Q2 2017
8/3/2017
78.40-1.88-6.05NA
Q1 2017
5/9/2017
66.03-1.52-5.25NA
Q4 2016
2/23/2017
62.33-1.50-4.70NA
Q3 2016
11/3/2016
38.71-1.15-4.19NA
Q2 2016
8/9/2016
36.86-1.08-3.88NA
Q1 2016
5/5/2016
34.79-0.97-3.70NA
Q4 2015
2/24/2016
30.75-0.99-3.39NA
Q3 2015
11/5/2015
53.03-0.84-2.97NA
Q2 2015
8/12/2015
62.47-0.90-2.63NA
Q1 2015
5/14/2015
58.29-0.66-6.30NA
Q4 2014
2/27/2015
43.45-0.57NANA
Q3 2014
11/11/2014
33.98-0.50NANA
Q2 2014
8/14/2014
28.81-4.57NANA
Quotes delayed 20 minutes

Email EnvelopeFree SAGE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sage Therapeutics (SAGE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SANA PE Ratio History
SAVA PE Ratio History
SBTX PE Ratio History
SCPH PE Ratio History
SCPS PE Ratio History
SCTL PE Ratio History
SCYX PE Ratio History
SDC PE Ratio History
SDGR PE Ratio History
SEEL PE Ratio History
How should the SAGE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Sage Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SAGE Historical PE Ratio page.

What is the average historical PE for SAGE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SAGE historical PE ratio using the annualized quarterly earnings method works out to 1.2.

What is the average historical PE for SAGE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SAGE historical PE ratio using the TTM earnings method works out to 5.0.

On this page we presented the SAGE Historical PE Ratio information for Sage Therapeutics' stock. The average SAGE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SAGE historical PE based on this TTM earnings result method is 5.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SAGE historical PE result, against the recent PE: when this page was posted on 11/9/2022, the most recent closing price for SAGE had been 32.20, and the most recent quarterly earnings result, annualized, was 72.76. Meanwhile, the most recent TTM earnings summed to 12.51. From these numbers, we calculate the recent SAGE PE on 11/9/2022 based on annualized quarterly EPS was 0.4. Based on SAGE's history, that recent PE is low relative to the historical average, with the recent PE 66.7% lower than the historical average PE across our data set for Sage Therapeutics. Looking at the recent SAGE PE on 11/9/2022 based on TTM EPS, we calculate the ratio at 2.6. Based on SAGE's history, that recent PE is low relative to the historical average, with the recent PE 48.0% lower than the average PE across our Sage Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on SAGE or any other given stock, valuation analysis for SAGE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Sage Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SAGE. Thanks for visiting, and the next time you need to research SAGE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding HTCO, Funds Holding BAB, SBRA Split History.

 

SAGE Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.